James E Dentzer - Net Worth and Insider Trading
James E Dentzer Net Worth
The estimated net worth of James E Dentzer is at least $725,649 dollars as of 2024-05-23. James E Dentzer is the President & CEO of Curis Inc and owns about 64,877 shares of Curis Inc (CRIS) stock worth over $725,649. Details can be seen in James E Dentzer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James E Dentzer has not made any transactions after 2022-01-31 and currently still holds the listed stock(s).
Transaction Summary of James E Dentzer
James E Dentzer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James E Dentzer owns 4 companies in total, including Curis Inc (CRIS) , Dicerna Pharmaceuticals Inc (DRNA) , and Amicus Therapeutics Inc (FOLD) among others .
Click here to see the complete history of James E Dentzer’s form 4 insider trades.
Insider Ownership Summary of James E Dentzer
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CRIS | Curis Inc | 2023-01-20 | director & President & CEO |
DRNA | Dicerna Pharmaceuticals Inc | 2015-01-09 | Chief Financial Officer |
FOLD | Amicus Therapeutics Inc | 2007-05-30 | Chief Financial Officer |
2022-09-29 | director |
James E Dentzer Latest Holdings Summary
James E Dentzer currently owns a total of 1 stock. James E Dentzer owns 64,877 shares of Curis Inc (CRIS) as of January 31, 2022, with a value of $725,649.
James E Dentzer Form 4 Trading Tracker
According to the SEC Form 4 filings, James E Dentzer has made a total of 3 transactions in Curis Inc (CRIS) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Curis Inc is the sale of 5,500 shares on January 31, 2022, which brought James E Dentzer around $17,160.
Insider Trading History of James E Dentzer
- 1
James E Dentzer Trading Performance
James E Dentzer Ownership Network
Ownership Network List of James E Dentzer
Ownership Network Relation of James E Dentzer
James E Dentzer Owned Company Details
What does Curis Inc do?
Who are the key executives at Curis Inc?
James E Dentzer is the director & President & CEO of Curis Inc. Other key executives at Curis Inc include CDO Jonathan B. Zung , CFO Diantha Duvall , and Head of Research & Development Robert Martell .
Curis Inc (CRIS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Curis Inc (CRIS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Curis Inc (CRIS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Curis Inc (CRIS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Curis Inc Insider Transactions
James E Dentzer Mailing Address
Above is the net worth, insider trading, and ownership report for James E Dentzer. You might contact James E Dentzer via mailing address: C/o Amicus Therapeutics, Inc., 6 Cedar Brook Drive, Cranbury Nj 08512.